
    
      Only patients who - regardless of this study - are scheduled and permitted to receive
      anti-TNF-alpha treatment because of their RA will be asked to participate. No patient will be
      recruited only for the sake of the study. The prescribing physicians will not be influenced
      by the study as to what form of anti-TNF-alpha therapy they should select.
    
  